FREDRIC J. FELDMAN, PH.D. - Corporate Board Profile

Capstone Holding Corp.

Filing Date	Source Excerpt
2001-04-16	Fredric J. Feldman, Ph.D., 61, has been the President of FJF Associates, a consultant to health care venture capital and emerging companies, since February 1992. From September 1995 to June 1996, he was the Chief Executive Officer of Biex, Inc. a women's healthcare company. Dr. Feldman returned to his position as Chief Executive Officer of Biex again in 1999. He served as Chief Executive Officer of Oncogenetics, Inc., a cancer genetics reference laboratory from 1992 to 1995. Between 1988 and 1992, Dr. Feldman was the President and Chief Executive Officer of Microgenics Corporation, a medical diagnostics company. He is a director of Sangstat Medical Corp., a publicly held biotech transplant drug company, and of Ostex International, Inc., a publicly held developer of diagnostics and therapeutics for skeletal and connective tissue diseases.
2002-04-15	Fredric J. Feldman, Ph.D., 62, has been the President of FJF Associates. (1) Member of the Executive Committee. (3) Member of the Compensation Committee. The Company pays non-employee directors an annual retainer of $12,000.
2003-04-17	FREDRIC J. FELDMAN, PH.D.(1)(3) Director since 1991 Fredric J. Feldman, Ph.D., 63, has been the President of FJF Associates, a consultant to health care venture capital and emerging companies, since February 1992. ... (1) Member of the Executive Committee. (3) Member of the Compensation Committee. During the year ended 2002, the Company paid non-employee directors an annual retainer of $12,000. Effective January 1, 2003, that amount was increased to $24,000, payable quarterly in advance. All directors are eligible for the grant of nonqualified stock options pursuant to the Company's 1997 Stock Option Plan.
2004-04-29	Fredric J. Feldman, Ph.D., 64, has been the President of FJF Associates, a consultant to health care venture capital and emerging companies, since February 1992. ... The Executive Committee, which acts on Board matters that arise between meetings of the full Board of Directors, consists of Dr. Feldman, Mr. Holliman and Mr. Howse and met four times during 2003. ... The Compensation Committee, which consists of Dr. Feldman and Mr. Howse, met one time during 2003. ... During the year ended 2003, the Company paid non-employee directors an annual retainer of $24,000, payable quarterly in advance. The Company issued options to acquire 20,000 non-qualified shares to each non-employee director on December 31, 2003. All such options vested immediately and were granted at the market price of $6.13 on the date of grant.
2005-03-07	Fredric J. Feldman, Ph.D., 65, has been the President of FJF Associates since February 1992. The Executive Committee consists of Dr. Feldman, Mr. Holliman and Mr. Howse and met four times during 2004. The Compensation Committee, which consists of Dr. Feldman and Mr. Howse, met one time during 2004. During the year ended 2004, the Company paid non-employee directors an annual retainer of $24,000 payable quarterly in advance.
2006-04-14	Fredric J. Feldman, Ph.D., 65, has been the President of FJF Associates... The Executive Committee, which acts on Board matters that arise between meetings of the full Board of Directors, consists of Dr. Feldman, Mr. Holliman and Mr. Howse and met five times during 2005... Effective February 11, 2006, Dr. Feldman replaced Mr. Holliman on the Audit Committee... The Compensation Committee, which consists of Dr. Feldman and Mr. Howse, met four times during 2005... During the year ended December 31, 2005, the Company paid non-employee directors an annual retainer of $24,000 payable quarterly in advance.
2007-04-09	Fredric J. Feldman, Ph.D., 66, has been the President of FJF Associates, a consultant to health care venture capital and emerging companies, since February 1992. ... (2) Member of the Audit Committee. ... (3) Member of the Compensation Committee. ... Compensation of Directors ... Fredric J. Feldman, Ph.D. Director 28,000 20,000 46,000 94,000
2008-04-11	Fredric J. Feldman, Ph.D., 67, has been the President of FJF Associates, a consultant to health care venture capital and emerging companies, since February 1992.
2009-04-10	Fredric J. Feldman, Ph.D., 68, has been President of FJF Associates since 1992. He has been CEO of several healthcare companies. He has been a director of a number of public and private companies. He is a member of the Executive Committee, Audit Committee, and Compensation Committee. Director compensation was $67,000 in 2008.
2010-04-12	Fredric J. Feldman, Ph.D., 69, has been the President of FJF Associates, a consultant to health care venture capital and emerging companies, since February 1992. ... Member of the Executive Committee. Member of the Audit Committee. Member of the Compensation Committee. ... The following table sets forth compensation awarded to, earned by or paid to the Company’s directors during the last fiscal year. ... Fredric J. Feldman, Ph.D. Director 62,000 Fees Earned or Paid in Cash, 12,000 Option Awards, Total 74,000.
2011-04-29	Fredric J. Feldman, Ph.D., 70, has been the President of FJF Associates since February 1992. The Executive Committee consists of Dr. Feldman, Mr. Holliman and Mr. Howse. The Audit Committee met five times in 2010 and consisted of Mr. Howse (Chairman), Dr. White and Dr. Feldman. Dr. Spiegel replaced Dr. Feldman in August 2010. The Compensation Committee consists of Dr. Feldman (Chairman), Mr. Howse and Dr. Spiegel (joined August 2010). Dr. Feldman received total compensation of $68,000 in 2010.
2012-05-10	Fredric J. Feldman, Ph.D., 70, has been the President of FJF Associates, a consultant to health care venture capital and emerging companies, since February 1992. The Board believes that Dr. Feldman’s over forty years of operating, scientific and business experience in the medical/biotech industry qualifies him for service on our board. (1) Member of the Audit Committee. (2) Member of the Compensation Committee. (3) Member of the Corporate Governance/Nominating Committee. The following table sets forth compensation awarded to, earned by or paid to the Company’s directors during the year ended December 31, 2011. Fredric J. Feldman, Ph.D. Director Fees Earned or Paid in Cash $64,000, Option Awards $3,000, Total $67,000.
2013-05-03	Fredric J. Feldman, Ph.D., 72, has been the President of FJF Associates, a consultant to health care venture capital and emerging companies, since February 1992 and has served as a director of the Company since 1991. ... (1) Member of the Audit Committee. (2) Member of the Compensation Committee. (3) Member of the Corporate Governance/Nominating Committee. ... The following table sets forth compensation awarded to, earned by or paid to the Company’s directors during the last fiscal year. ... Fredric J. Feldman, Ph.D. received total compensation of $34,000.
2014-05-02	Fredric J. Feldman, Ph.D., 73, has been the President of FJF Associates, a consultant to health care venture capital and emerging companies, since February 1992 and has served as a director of the Company since 1991. He is a member of the Audit Committee, Compensation Committee, and Corporate Governance/Nominating Committee. The following table sets forth compensation awarded to the Company’s directors during the last fiscal year. Fredric J. Feldman, Ph.D. received total compensation of $53,000.
2015-05-08	Fredric J. Feldman, Ph.D., 74, has served as a director of the Company since 1991. The Compensation Committee consists of Dr. Feldman (Chairman) and Mr. Howse. The Corporate Governance/Nominating Committee consists of Dr. Feldman (Chairman) and Mr. Howse. The following table sets forth compensation awarded to the Company’s directors during the last fiscal year. Fredric J. Feldman received total compensation of $53,000.
2019-07-10	Fredric J. Feldman, Ph.D., 78, has been the President of FJF Associates, a consultant to health care venture capital and emerging companies, since February 1992 and has served as a director of the Company since 1991. ... (1) Member of the Audit Committee. (2) Member of the Compensation Committee. (3) Member of the Corporate Governance/Nominating Committee. ... During the year ended December 31, 2018, the Company did not pay Directors’ Board fees to Mr. Holliman, Mr. Toporek or Mr. Lipman. In 2018, Mr. Howse and Dr. Feldman were each paid Board fees of $10,000 in cash and each earned an additional Board Fee of $10,000, payable July 15, 2020, or earlier if certain transactions occur. All directors are eligible for a grant of non-qualified stock options pursuant to the Company’s 2015 Equity Incentive Plan. The Company did not grant any options to directors in 2018.